Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization

Biochemical and Biophysical Research Communications

Volumn 374, Issue 1, 2008, Pages 38-43

  Hijioka, Kuniaki ^a   Sonoda, Koh Hei ^a   Tsutsumi Miyahara, Chikako ^a   Fujimoto, Takeshi ^a   Oshima, Yuji ^a   Taniguchi, Masaru ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Innate immunity; Natural killer T cell; Vascular endothelial growth factor

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANGIOGENIC FACTOR; CD1D ANTIGEN; CXCL16 CHEMOKINE; INTERLEUKIN 6;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INFLAMMATION; KNOCKOUT MOUSE; LOW LEVEL LASER THERAPY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD1; CHEMOKINE CXCL6; CHOROIDAL NEOVASCULARIZATION; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GALACTOSYLCERAMIDES; GENES, T-CELL RECEPTOR ALPHA; INTERLEUKIN-6; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIGMENT EPITHELIUM OF EYE; SPLEEN; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 47749090863     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.080     Document Type: Article

References (20)

1. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
2. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Ferrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
3. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vence M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
4. Patel N., Ohbayashi M., Nugent A.K., Ramcha K., Toda M., Chau K.Y., Bunce C., Webster A., Bird A.C., Ono S.J., and Chong V. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115 (2005) 422-430
5. Tsutsumi-Miyahara C., Sonoda K.H., Egashira K., Ishibashi M., Qiao H., Oshima T., Murata T., Miyazaki M., Charo I.F., Hamano S., and Ishibashi T. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularization. Br. J. Ophthalmol. 88 (2004) 1217-1222
6. + T lymphocytes. Science 268 (1995) 863-865
7. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Valpha14NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
8. + T cell development and early IL-4 production in CD1-Deficient mice. Immunity 6 (1997) 459-467
9. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., and Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6 (1997) 469-477
10. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
11. Dobi E.T., Puliafito C.A., and Destro M. A new model of experimental choroidal neovascularization in the rat. Arch. Ophthalmol. 107 (1989) 264-269
12. + T cells. Eur. J. Immunol. 27 (1997) 1576-1579
13. Jiang X., Shimaoka T., Kojo S., Harada M., Watarai H., Wakao H., Ohkohchi N., Yonehara S., Taniguchi M., and Seino K. Critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J. Immunol. 175 (2005) 2051-2055
14. Wilson M.T., Johansson C., Olivares-Villagomez D., Singh A.K., Stanic A.K., Wang C.R., Joyce S., Wick M.J., and Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100 (2003) 10913-10918
15. Ishibashi T., Hata Y., Yoshikawa H., Nakagawa K., Sueishi K., and Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Grafes. Arch. Clin. Exp. Ophthalmol. 235 (1997) 159-167
16. Yi X., Ogata N., Komada M., Yamamoto C., Takahashi K., Omori K., and Uyama M. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Grafes. Arch. Clin. Exp. Ophthalmol. 235 (1997) 313-319
17. Nieuwenhuis E.E., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., Corazza N., Colgan S.P., Onderdonk A.B., and Blumberg R.S. CD1d-dependent macrophage-mediated clearance of pseudomonas aeruginosa from lung. Nat. Med. 8 (2002) 588-593
18. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271 (1996) 736-741
19. Huang S.P., Wu M.S., Shun C.T., Wang H.P., Lin M.T., Kuo M.L., and Lin J.T. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J. Biomed. Sci. 11 (2004) 517-527
20. Hatzi E., Murphy C., Zoephel A., Rasmussen H., Morbidelli L., Ahorn H., Kunisada K., Tontsch U., Klenk M., Yamauchi-Takihara K., Ziche M., Rofstad E.K., Schweigerer L., and Fotsis T. N-myc oncogene overexpression down-regulates IL-6; evidence that inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene 21 (2002) 3552-3561